查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1931272

神经外科植入耗材市场（按产品类型、材料、最终用户和应用划分），全球预测（2026-2032）

Neurosurgery Implant Consumable Market by Product Type, Material, End User, Application - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 196 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2025 年，神经外科植入耗材市场价值将达到 16.5 亿美元，到 2026 年将成长至 17.9 亿美元，到 2032 年将达到 32.2 亿美元，年复合成长率为 10.05%。

关键市场统计数据
基准年 2025 16.5亿美元
预计年份：2026年 17.9亿美元
预测年份 2032 32.2亿美元
复合年增长率 (%) 10.05%

对神经外科植入耗材环境进行全面概述，详细阐述临床需求、供应压力和影响其应用发展的创新方向。

神经外科植入耗材的市场环境呈现出快速的技术进步、不断变化的临床通讯协定以及日益增长的采购压力等特点，这为产品开发商、医院采购人员和专科诊所製定了战略重点。临床医生越来越倾向于选择兼俱动态性能、良好操作特性以及与微创手术流程相容性的植入和耗材。因此，製造商正增加对材料科学、模组化设计和术中效率的投入，以缩短手术时间并改善患者预后。

材料创新、数位整合和流程改善如何共同重塑神经外科耗材的竞争格局和临床应用

神经外科植入耗材领域正经历变革性的转变，这得益于材料科学、数位化整合和外科技术创新的整合。多聚合物和碳纤维复合材料凭藉其卓越的强度重量比和影像相容性，重新定义了传统的性能指标；而积层製造技术则实现了以往难以企及的复杂设计。这些进步催生了更符合患者解剖结构和手术流程的新型器械几何形状，加速了其临床应用。

评估关税压力如何推动神经外科供应链的结构调整、采购收紧和本地製造投资

对医疗设备原料和成品征收关税，对製造商、医疗系统和采购商而言都是复杂的问题。关税政策会改变原料和零件的相对成本，从而影响上游采购决策，并可能促使供应链从易受影响的地区转向多元化的供应基地。这可能会促使製造商采取双重采购安排和库存管理策略，以降低政策突变带来的风险。

一个整合的细分框架，揭示了产品类型、材料选择、最终用户环境和临床应用如何决定产品采用路径和开发者优先顺序。

神经外科植入耗材市场的细分揭示了需求的细微差别，反映了不同产品、材料、终端用户和应用领域中的临床需求和性能权衡。产品类型包括颅骨板、止血钳、椎间融合器、椎弓骨钉和脊椎棒。颅骨板本身又分为永久性和可吸收性两种选择，外科医师需要权衡长期耐用性和可吸收性的利弊。止血钳依出血特性、组织亲和性和操作性能，分为胶原蛋白基、明胶基和氧化再生纤维素配方。椎间器有复合材料、PEEK 和钛合金三种材质，每种材质的透射性和动态性能各不相同。椎弓骨钉的选择则体现在膨胀螺钉和传统螺钉之间的权衡，反映了即时稳定性与简化植入之间的取舍。脊柱棒通常由不銹钢或钛製成，选择依据是刚度特性、疲劳寿命和成像的考虑。

美洲、欧洲、中东和非洲以及亚太地区的区域趋势和市场接受度差距正在影响市场进入和扩大策略。

区域趋势对神经外科植入耗材的监管路径、采购行为和临床应用曲线有显着影响。美洲的特点是拥有高度集中的先进临床中心、一体化医院系统和成熟的医疗保险报销体系。这些因素共同创造了一种市场环境，在这种环境下，能够显着缩短手术时间和降低併发症发生率的创新技术能够迅速被市场接受，而集团采购组织在供应商选择方面也拥有举足轻重的影响力。

现有製造商、专业创新者和伙伴关係主导策略如何重新定义竞争优势和采购决策

神经外科植入耗材领域的竞争格局由成熟製造商、专业化的中型企业和敏捷的创新者共同构成​​。历史悠久的跨国医疗设备公司凭藉其广泛的分销网络和稳固的临床关係，持续在医院系统和专科诊所中保持市场地位。这些公司通常拥有全面的产品系列组合、完善的监管支援和临床培训项目，这为寻求同等市场覆盖率的新进入者设定了很高的进入门槛。

将临床创新、供应链韧性和商业模式演进连结起来，创造长期价值的可操作策略重点

产业领导者应采取多管齐下的策略，平衡创新投资、营运韧性和商业性纪律。首先，优先投资于能够解决明确临床挑战的材料和设计，例如提高影像相容性、缩短手术时间以及提升微创手术的易用性。将产品开发与临床医生共同设计以及有针对性的临床试验结合，可以加快产品实用化速度。其次，透过供应商多元化、尽可能进行区域性製造地以及利用先进的库存和需求预测工具提高供应链视觉性，增强供应链韧性。这种方法既能维持服务水平，又能降低关税和贸易波动带来的风险。

我们采用严格的三角调查方法，结合临床访谈、监管分析和供应链评估，以确保获得可靠、可操作的见解。

本分析采用三角测量法，整合质性和量性数据，以得出可靠且可重复的调查方法结果。为了解关键相关人员的实践模式、采购动机和未满足的需求，研究人员与外科医生、采购人员和临床营运经理进行了结构化访谈。此外，研究人员还透过同行评审的临床文献、监管文件和技术白皮书收集了二手证据，用于检验临床声明，并梳理医疗设备的分类和材料特性。

对神经外科植入耗材的韧性和机会进行临床、材料和商业性因素的简要综合分析

现代神经外科植入耗材市场瞬息万变，临床需求、材料创新和采购复杂性交织其中。该行业的特点是聚合物科学和器械几何形状的持续创新、与数位化手术平台的深度整合，以及在贸易政策不断变化的背景下对价值链稳健性的日益重视。临床领导者关注的是能够显着提高术中效率和病患疗效的解决方案，而相关人员则要求提供价值证明和可靠的供应保障。

目录

第一章：序言

第二章调查方法

  • 研究设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查前提
  • 调查限制

第三章执行摘要

  • 首席体验长观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 产业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 上市策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会地图
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章 神经外科植入耗材市场（依产品类型划分）

  • 头骨板
  • 止血剂
  • 椎弓骨钉
  • 脊椎桿

9. 神经外科植入耗材市场（依材料分类）

  • 复合聚合物
    • 生物可吸收聚合物
    • 碳纤维复合材料
  • PEEK
  • 不銹钢
  • 钛

第十章 神经外科植入耗材市场（依最终用户划分）

  • 门诊手术中心
  • 医院
    • 私立医院
    • 公立医院
  • 专科诊所
    • 神经内科诊所
    • 脊椎中心

第十一章 神经外科植入耗材市场（依应用领域划分）

  • 颅骨
    • 重组
    • 创伤修復
  • 脊椎
    • 颈椎
    • 腰椎
    • 胸椎
  • 创伤
    • 硬脑膜修復
    • 颅骨骨折修復
  • 瘤
    • 切片检查引导
    • 肿瘤植入

第十二章 神经外科植入耗材市场（依地区划分）

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十三章 神经外科植入耗材市场（依类别划分）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十四章 各国神经外科植入耗材市场

  • 我们
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

15. 美国神经外科植入耗材市场

第十六章：中国神经外科植入耗材市场

第十七章 竞争格局

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • Abbott Laboratories
  • Aesculap Implant Systems, LLC
  • B. Braun SE
  • Boston Scientific Corporation
  • Craniotech Solutions Pvt. Ltd.
  • DePuy Synthes, Inc.
  • Globus Medical, Inc.
  • Integra LifeSciences Corporation
  • Johnson & Johnson Services, Inc.
  • LivaNova PLC
  • Medtronic plc
  • Neuro France Implants SAS
  • NuVasive, Inc.
  • Orthofix Medical Inc.
  • Penumbra, Inc.
  • Siora Surgicals Pvt. Ltd.
  • Smith & Nephew plc
  • Stryker Corporation
  • Terumo Corporation
  • Zimmer Biomet Holdings, Inc.
Product Code: MRR-7B550E008DFC

The Neurosurgery Implant Consumable Market was valued at USD 1.65 billion in 2025 and is projected to grow to USD 1.79 billion in 2026, with a CAGR of 10.05%, reaching USD 3.22 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 1.65 billion
Estimated Year [2026] USD 1.79 billion
Forecast Year [2032] USD 3.22 billion
CAGR (%) 10.05%

A comprehensive orientation to the neurosurgery implant consumables environment detailing clinical imperatives, supply pressures, and innovation vectors shaping adoption

The neurosurgery implant consumables landscape is characterized by rapid technological refinement, shifting clinical protocols, and evolving procurement pressures that together define the strategic priorities of product developers, hospital procurement leaders, and specialty clinics. Clinicians increasingly demand implants and consumables that balance biomechanical performance with favorable handling characteristics and compatibility with minimally invasive workflows. Consequently, manufacturers are investing in materials science, modularity, and intraoperative efficiency to reduce procedural time and improve patient outcomes.

At the same time, supply chain resiliency and regulatory compliance have moved to the forefront of strategic planning. Manufacturers and health systems are navigating raw material sourcing, sterilization logistics, and traceability requirements while aligning product portfolios with evidence-based clinical guidelines. As a result, market participants who couple clinical insight with robust supply and quality frameworks are finding greater traction with integrated delivery networks and specialty centers. Moving forward, the interplay of clinical need, material innovation, and operational rigor will determine which technologies become standard of care and which will be niche offerings.

How materials innovation, digital integration, and procedural evolution are jointly reshaping competitive dynamics and clinical adoption in neurosurgery consumables

The neurosurgery implant consumables sector is undergoing transformative shifts driven by converging innovations in materials science, digital integration, and procedural technique. Composite polymers and carbon fiber composites are redefining expected performance metrics by offering strength-to-weight advantages alongside imaging compatibility, while additive manufacturing enables design complexity that was previously unattainable. These advances are unlocking new device form factors that better conform to patient anatomy and surgical workflows, thereby accelerating clinical acceptance.

Concurrently, digital tools such as intraoperative navigation, advanced imaging, and surgical planning platforms are tightly coupling with implant design to enable precision placement and personalized constructs. Transitioning from one-size-fits-most approaches toward patient-specific solutions, these technologies drive demand for implants and consumables that are compatible with navigation and imaging modalities. Moreover, reimbursement and regulatory trends are incentivizing shorter hospital stays and outpatient procedures, prompting manufacturers to prioritize products that reduce operative time and complications. Taken together, these shifts are reshaping competitive dynamics and raising the bar for manufacturers seeking durable clinical and commercial differentiation.

Assessing how tariff-driven pressures are catalyzing supply chain reconfiguration, procurement rigor, and localized manufacturing investments within the neurosurgery supply chain

The imposition of tariffs on medical device inputs and finished goods introduces a complex set of considerations for manufacturers, health systems, and purchasers. Tariff policies affect upstream sourcing decisions by altering the relative cost of raw materials and components, which in turn can shift supply chains away from vulnerable geographies and toward diversified supplier bases. As a result, manufacturers may accelerate dual-sourcing arrangements and stockkeeping strategies to mitigate exposure to sudden policy changes.

In parallel, tariffs create pressure on pricing strategies across commercial channels. Procurement teams within hospitals and ambulatory surgery centers respond by intensifying supplier negotiations, exploring alternative materials or product families, and prioritizing total cost of ownership over unit price. Regulatory compliance and customs processes can also lengthen lead times, prompting more conservative inventory policies and a heightened focus on demand forecasting accuracy. Importantly, the tariff environment incentivizes nearshoring and localized manufacturing investments for those organizations with the capital to reconfigure production footprints, while smaller suppliers may pursue partnerships or licensing models to maintain market access. Ultimately, the cumulative effect of tariffs is less about uniform cost increases and more about a rebalancing of supply chain strategies, pricing discipline, and capital allocation toward resilience and responsiveness.

An integrated segmentation framework revealing how product type, material choice, end user environment, and clinical application define adoption pathways and developer priorities

Segmentation in the neurosurgery implant consumables domain reveals nuanced demand pockets that reflect clinical need and performance trade-offs across product, material, end user, and application vectors. Product type distinctions include cranial plates, hemostatic agents, interbody cages, pedicle screws, and spinal rods; cranial plates themselves bifurcate into permanent and resorbable options as surgeons weigh long-term durability against resorption benefits. Hemostatic agents span collagen-based, gelatin-based, and oxidized regenerated cellulose formulations, each selected according to bleeding profile, tissue affinity, and handling characteristics. Interbody cages are offered in composite, PEEK, and titanium variants, which present different radiographic profiles and biomechanical behaviors. Pedicle screw choices contrast expandable screws with traditional designs, reflecting trade-offs between immediate purchase stability and simplified insertion. Spinal rods are commonly manufactured in stainless steel or titanium, with selection driven by stiffness profiles, fatigue life, and imaging considerations.

Material segmentation further refines performance expectations and clinical compatibility. Composite polymers encompass bioresorbable polymers and carbon fiber composites, while PEEK, stainless steel, and titanium remain foundational choices for their established mechanical properties and regulatory histories. End user segmentation clarifies procurement and usage environments, ranging from ambulatory surgery centers to hospitals and specialty clinics; within hospitals the private and public distinction affects purchasing cycles and capital approvals, whereas specialty clinics such as neurology clinics and dedicated spine centers prioritize procedures with repeatable workflows and predictable consumable consumption. Application segmentation frames the clinical scenarios in which implants are deployed, stretching from cranial reconstruction and trauma repair to spinal interventions across cervical, lumbar, and thoracic regions; trauma use cases include dural repair and skull fracture repair, while tumor-related applications involve biopsy guidance and oncology implant strategies. Integrating these segmentation layers offers a multidimensional view of product positioning, clinical fitment, and procurement pathways that is essential for targeted product development and commercial planning.

Regional dynamics and adoption differentials across the Americas, Europe Middle East & Africa, and Asia-Pacific that determine market entry and scaling tactics

Regional dynamics materially influence the regulatory pathways, procurement behaviors, and clinical adoption curves for neurosurgery implant consumables. The Americas are characterized by a high concentration of advanced clinical centers, consolidated hospital systems, and mature reimbursement frameworks. These factors create a market environment where innovation that demonstrably reduces procedural time and complication rates can gain rapid acceptance, and where group purchasing organizations exert significant influence over supplier selection.

Europe, Middle East & Africa presents heterogeneous regulatory and procurement landscapes that demand regionally tailored market approaches. Western European markets typically emphasize evidence generation, health technology assessment, and clinician-driven adoption, while certain Middle Eastern markets prioritize infrastructure expansion and rapid capability building. In parts of Africa, access and supply chain reliability remain central constraints, influencing the prioritization of robust, cost-efficient solutions. Asia-Pacific exhibits a wide spectrum of maturity; advanced markets emphasize local manufacturing and regulatory harmonization, while emerging economies are adopting implants and consumables more selectively, often driven by growing hospital capacity and investments in surgical training. Across all regions, strategic imperatives include navigating local regulatory requirements, building clinical evidence aligned with regional practice patterns, and structuring commercial models that reflect procurement channel diversity and reimbursement realities.

How legacy manufacturers, specialized innovators, and partnership-driven strategies are redefining competitive advantage and procurement decisions

Competitive positioning in the neurosurgery implant consumables arena is shaped by a blend of enduring legacy manufacturers, specialized mid-tier players, and agile innovators. Legacy multinational device companies continue to leverage broad distribution networks and established clinical relationships to maintain presence across hospital systems and specialty clinics. These firms often couple comprehensive product portfolios with extensive regulatory support and clinical training programs, creating high barriers for new entrants seeking equivalent reach.

Specialized manufacturers and focused startups, by contrast, differentiate through rapid iteration on materials and device geometry, closer collaboration with key opinion leaders, and targeted pilot programs in high-value centers. These entities are adept at translating clinical feedback into product refinements and can therefore capture niche segments more quickly. Strategic partnerships, co-development agreements, and targeted acquisitions remain common playbooks for scaling technologies and accessing new channels. Additionally, partnerships between implant manufacturers and digital-navigation or intraoperative imaging providers are becoming increasingly relevant, as integration across the clinical workflow enhances device value. For procurement and clinical leaders, supplier selection increasingly hinges on a combination of clinical evidence, supply chain reliability, post-market surveillance capabilities, and the vendor's willingness to engage in outcomes-based or value-based contracting frameworks.

Actionable strategic priorities that link clinical innovation, supply chain resilience, and commercial model evolution to capture long-term value

Industry leaders should adopt a multi-pronged strategy that balances innovation investment with operational resilience and commercial discipline. First, prioritize materials and design investments that align with clear clinical pain points, such as enhanced imaging compatibility, reduced operative time, or improved handling for minimally invasive approaches. Coupling product development with clinician co-design and targeted clinical pilots will accelerate meaningful adoption. Second, strengthen supply chain resilience by diversifying suppliers, developing regional manufacturing options where feasible, and improving visibility through advanced inventory and demand forecasting tools. This approach reduces exposure to tariff and trade volatility while preserving service levels.

Third, evolve commercial models to reflect stakeholder incentives; consider value-based contracting, bundled-service offerings, and clinically focused training programs that lower the barrier to adoption. Fourth, invest in post-market surveillance and real-world evidence generation to substantiate claims and support payer conversations. Finally, pursue selective partnerships with digital navigation and imaging providers to offer integrated solutions that enhance intraoperative precision. Taken together, these actions will enable organizations to deliver clinically meaningful innovation while managing risk and improving alignment with purchaser priorities.

A rigorous triangulated research methodology combining clinical interviews, regulatory analysis, and supply chain assessment to ensure reliable actionable insights

The research approach underpinning this analysis employs a triangulated methodology that synthesizes qualitative and quantitative inputs to produce robust, reproducible insights. Primary stakeholder engagement includes structured interviews with surgeons, procurement leaders, and clinical operations managers to capture practice patterns, purchasing drivers, and unmet needs. Secondary evidence was gathered through peer-reviewed clinical literature, regulatory filings, and technology whitepapers to validate clinical claims and to map device classifications and material properties.

Additionally, supply chain and procurement analyses were constructed from supplier disclosures, customs filings, and trade policy documentation to assess vulnerability points and sourcing strategies. Cross-validation exercises compared clinical inputs with supplier capabilities to identify alignment and gaps. Throughout, emphasis was placed on transparency of assumptions, documentation of data provenance, and sensitivity analysis where policy or market variables could materially influence strategic choices. This layered methodology supports actionable conclusions while acknowledging uncertainty and the need for ongoing monitoring of clinical, regulatory, and policy developments.

A concise synthesis of clinical, material, and commercial forces that converge to define resilience and opportunity in neurosurgery implant consumables

Modern neurosurgery implant consumables occupy a dynamic intersection of clinical demand, materials innovation, and procurement complexity. The landscape is characterized by steady innovation in polymer science and device geometry, deeper integration with digital surgical platforms, and increasing emphasis on supply chain robustness amid shifting trade policies. Clinical leaders are focused on solutions that demonstrably improve intraoperative efficiency and patient outcomes, while procurement stakeholders require evidence of value and reliable supply arrangements.

Looking ahead, manufacturers that integrate clinician-driven innovation with resilient sourcing and compelling real-world evidence will be best positioned to succeed. Strategic partnerships and integrated solutions will continue to erode traditional product siloes, and organizations that proactively adapt commercial models to align with payer and provider incentives will capture disproportionate value. In summary, success in this sector requires balancing clinical excellence, operational discipline, and commercial creativity to navigate an increasingly complex but opportunity-rich environment.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Neurosurgery Implant Consumable Market, by Product Type

  • 8.1. Cranial Plates
  • 8.2. Hemostatic Agents
  • 8.3. Pedicle Screws
  • 8.4. Spinal Rods

9. Neurosurgery Implant Consumable Market, by Material

  • 9.1. Composite Polymers
    • 9.1.1. Bioresorbable Polymers
    • 9.1.2. Carbon Fiber Composites
  • 9.2. Peek
  • 9.3. Stainless Steel
  • 9.4. Titanium

10. Neurosurgery Implant Consumable Market, by End User

  • 10.1. Ambulatory Surgery Centers
  • 10.2. Hospitals
    • 10.2.1. Private Hospitals
    • 10.2.2. Public Hospitals
  • 10.3. Specialty Clinics
    • 10.3.1. Neurology Clinics
    • 10.3.2. Spine Centers

11. Neurosurgery Implant Consumable Market, by Application

  • 11.1. Cranial
    • 11.1.1. Reconstruction
    • 11.1.2. Trauma Repair
  • 11.2. Spinal
    • 11.2.1. Cervical
    • 11.2.2. Lumbar
    • 11.2.3. Thoracic
  • 11.3. Trauma
    • 11.3.1. Dural Repair
    • 11.3.2. Skull Fracture Repair
  • 11.4. Tumor
    • 11.4.1. Biopsy Guidance
    • 11.4.2. Oncology Implants

12. Neurosurgery Implant Consumable Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Neurosurgery Implant Consumable Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Neurosurgery Implant Consumable Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. United States Neurosurgery Implant Consumable Market

16. China Neurosurgery Implant Consumable Market

17. Competitive Landscape

  • 17.1. Market Concentration Analysis, 2025
    • 17.1.1. Concentration Ratio (CR)
    • 17.1.2. Herfindahl Hirschman Index (HHI)
  • 17.2. Recent Developments & Impact Analysis, 2025
  • 17.3. Product Portfolio Analysis, 2025
  • 17.4. Benchmarking Analysis, 2025
  • 17.5. Abbott Laboratories
  • 17.6. Aesculap Implant Systems, LLC
  • 17.7. B. Braun SE
  • 17.8. Boston Scientific Corporation
  • 17.9. Craniotech Solutions Pvt. Ltd.
  • 17.10. DePuy Synthes, Inc.
  • 17.11. Globus Medical, Inc.
  • 17.12. Integra LifeSciences Corporation
  • 17.13. Johnson & Johnson Services, Inc.
  • 17.14. LivaNova PLC
  • 17.15. Medtronic plc
  • 17.16. Neuro France Implants SAS
  • 17.17. NuVasive, Inc.
  • 17.18. Orthofix Medical Inc.
  • 17.19. Penumbra, Inc.
  • 17.20. Siora Surgicals Pvt. Ltd.
  • 17.21. Smith & Nephew plc
  • 17.22. Stryker Corporation
  • 17.23. Terumo Corporation
  • 17.24. Zimmer Biomet Holdings, Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL NEUROSURGERY IMPLANT CONSUMABLE MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL NEUROSURGERY IMPLANT CONSUMABLE MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY MATERIAL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. UNITED STATES NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 12. CHINA NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY CRANIAL PLATES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY CRANIAL PLATES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY CRANIAL PLATES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY HEMOSTATIC AGENTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY HEMOSTATIC AGENTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY HEMOSTATIC AGENTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY PEDICLE SCREWS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY PEDICLE SCREWS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY PEDICLE SCREWS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY SPINAL RODS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY SPINAL RODS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY SPINAL RODS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY COMPOSITE POLYMERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY COMPOSITE POLYMERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY COMPOSITE POLYMERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY COMPOSITE POLYMERS, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY BIORESORBABLE POLYMERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY BIORESORBABLE POLYMERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY BIORESORBABLE POLYMERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY CARBON FIBER COMPOSITES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY CARBON FIBER COMPOSITES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY CARBON FIBER COMPOSITES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY PEEK, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY PEEK, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY PEEK, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY STAINLESS STEEL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY STAINLESS STEEL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY STAINLESS STEEL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY TITANIUM, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY TITANIUM, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY TITANIUM, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY PRIVATE HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY PRIVATE HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY PUBLIC HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY PUBLIC HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY SPECIALTY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY SPECIALTY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY SPECIALTY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY NEUROLOGY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY NEUROLOGY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY NEUROLOGY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY SPINE CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY SPINE CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY SPINE CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY CRANIAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY CRANIAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY CRANIAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY CRANIAL, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY RECONSTRUCTION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY RECONSTRUCTION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY RECONSTRUCTION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY TRAUMA REPAIR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY TRAUMA REPAIR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY TRAUMA REPAIR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY SPINAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY SPINAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY SPINAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY SPINAL, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY CERVICAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY CERVICAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY CERVICAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY LUMBAR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY LUMBAR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY LUMBAR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY THORACIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY THORACIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY THORACIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY TRAUMA, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY TRAUMA, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY TRAUMA, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY TRAUMA, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY DURAL REPAIR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY DURAL REPAIR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY DURAL REPAIR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY SKULL FRACTURE REPAIR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY SKULL FRACTURE REPAIR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY SKULL FRACTURE REPAIR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY TUMOR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY TUMOR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY TUMOR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY TUMOR, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY BIOPSY GUIDANCE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY BIOPSY GUIDANCE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY BIOPSY GUIDANCE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY ONCOLOGY IMPLANTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY ONCOLOGY IMPLANTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY ONCOLOGY IMPLANTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 104. AMERICAS NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 105. AMERICAS NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 106. AMERICAS NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 107. AMERICAS NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY COMPOSITE POLYMERS, 2018-2032 (USD MILLION)
  • TABLE 108. AMERICAS NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 109. AMERICAS NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 110. AMERICAS NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY SPECIALTY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 111. AMERICAS NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 112. AMERICAS NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY CRANIAL, 2018-2032 (USD MILLION)
  • TABLE 113. AMERICAS NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY SPINAL, 2018-2032 (USD MILLION)
  • TABLE 114. AMERICAS NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY TRAUMA, 2018-2032 (USD MILLION)
  • TABLE 115. AMERICAS NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY TUMOR, 2018-2032 (USD MILLION)
  • TABLE 116. NORTH AMERICA NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 117. NORTH AMERICA NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 118. NORTH AMERICA NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 119. NORTH AMERICA NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY COMPOSITE POLYMERS, 2018-2032 (USD MILLION)
  • TABLE 120. NORTH AMERICA NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 121. NORTH AMERICA NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 122. NORTH AMERICA NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY SPECIALTY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 123. NORTH AMERICA NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 124. NORTH AMERICA NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY CRANIAL, 2018-2032 (USD MILLION)
  • TABLE 125. NORTH AMERICA NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY SPINAL, 2018-2032 (USD MILLION)
  • TABLE 126. NORTH AMERICA NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY TRAUMA, 2018-2032 (USD MILLION)
  • TABLE 127. NORTH AMERICA NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY TUMOR, 2018-2032 (USD MILLION)
  • TABLE 128. LATIN AMERICA NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 129. LATIN AMERICA NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 130. LATIN AMERICA NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 131. LATIN AMERICA NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY COMPOSITE POLYMERS, 2018-2032 (USD MILLION)
  • TABLE 132. LATIN AMERICA NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 133. LATIN AMERICA NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 134. LATIN AMERICA NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY SPECIALTY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 135. LATIN AMERICA NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 136. LATIN AMERICA NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY CRANIAL, 2018-2032 (USD MILLION)
  • TABLE 137. LATIN AMERICA NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY SPINAL, 2018-2032 (USD MILLION)
  • TABLE 138. LATIN AMERICA NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY TRAUMA, 2018-2032 (USD MILLION)
  • TABLE 139. LATIN AMERICA NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY TUMOR, 2018-2032 (USD MILLION)
  • TABLE 140. EUROPE, MIDDLE EAST & AFRICA NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 141. EUROPE, MIDDLE EAST & AFRICA NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 142. EUROPE, MIDDLE EAST & AFRICA NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 143. EUROPE, MIDDLE EAST & AFRICA NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY COMPOSITE POLYMERS, 2018-2032 (USD MILLION)
  • TABLE 144. EUROPE, MIDDLE EAST & AFRICA NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 145. EUROPE, MIDDLE EAST & AFRICA NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 146. EUROPE, MIDDLE EAST & AFRICA NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY SPECIALTY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 147. EUROPE, MIDDLE EAST & AFRICA NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 148. EUROPE, MIDDLE EAST & AFRICA NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY CRANIAL, 2018-2032 (USD MILLION)
  • TABLE 149. EUROPE, MIDDLE EAST & AFRICA NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY SPINAL, 2018-2032 (USD MILLION)
  • TABLE 150. EUROPE, MIDDLE EAST & AFRICA NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY TRAUMA, 2018-2032 (USD MILLION)
  • TABLE 151. EUROPE, MIDDLE EAST & AFRICA NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY TUMOR, 2018-2032 (USD MILLION)
  • TABLE 152. EUROPE NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 153. EUROPE NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 154. EUROPE NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 155. EUROPE NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY COMPOSITE POLYMERS, 2018-2032 (USD MILLION)
  • TABLE 156. EUROPE NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 157. EUROPE NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 158. EUROPE NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY SPECIALTY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 159. EUROPE NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 160. EUROPE NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY CRANIAL, 2018-2032 (USD MILLION)
  • TABLE 161. EUROPE NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY SPINAL, 2018-2032 (USD MILLION)
  • TABLE 162. EUROPE NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY TRAUMA, 2018-2032 (USD MILLION)
  • TABLE 163. EUROPE NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY TUMOR, 2018-2032 (USD MILLION)
  • TABLE 164. MIDDLE EAST NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 165. MIDDLE EAST NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 166. MIDDLE EAST NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 167. MIDDLE EAST NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY COMPOSITE POLYMERS, 2018-2032 (USD MILLION)
  • TABLE 168. MIDDLE EAST NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 169. MIDDLE EAST NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 170. MIDDLE EAST NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY SPECIALTY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 171. MIDDLE EAST NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 172. MIDDLE EAST NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY CRANIAL, 2018-2032 (USD MILLION)
  • TABLE 173. MIDDLE EAST NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY SPINAL, 2018-2032 (USD MILLION)
  • TABLE 174. MIDDLE EAST NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY TRAUMA, 2018-2032 (USD MILLION)
  • TABLE 175. MIDDLE EAST NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY TUMOR, 2018-2032 (USD MILLION)
  • TABLE 176. AFRICA NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 177. AFRICA NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 178. AFRICA NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 179. AFRICA NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY COMPOSITE POLYMERS, 2018-2032 (USD MILLION)
  • TABLE 180. AFRICA NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 181. AFRICA NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 182. AFRICA NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY SPECIALTY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 183. AFRICA NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 184. AFRICA NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY CRANIAL, 2018-2032 (USD MILLION)
  • TABLE 185. AFRICA NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY SPINAL, 2018-2032 (USD MILLION)
  • TABLE 186. AFRICA NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY TRAUMA, 2018-2032 (USD MILLION)
  • TABLE 187. AFRICA NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY TUMOR, 2018-2032 (USD MILLION)
  • TABLE 188. ASIA-PACIFIC NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 189. ASIA-PACIFIC NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 190. ASIA-PACIFIC NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 191. ASIA-PACIFIC NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY COMPOSITE POLYMERS, 2018-2032 (USD MILLION)
  • TABLE 192. ASIA-PACIFIC NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 193. ASIA-PACIFIC NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 194. ASIA-PACIFIC NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY SPECIALTY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 195. ASIA-PACIFIC NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 196. ASIA-PACIFIC NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY CRANIAL, 2018-2032 (USD MILLION)
  • TABLE 197. ASIA-PACIFIC NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY SPINAL, 2018-2032 (USD MILLION)
  • TABLE 198. ASIA-PACIFIC NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY TRAUMA, 2018-2032 (USD MILLION)
  • TABLE 199. ASIA-PACIFIC NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY TUMOR, 2018-2032 (USD MILLION)
  • TABLE 200. GLOBAL NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 201. ASEAN NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 202. ASEAN NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 203. ASEAN NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 204. ASEAN NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY COMPOSITE POLYMERS, 2018-2032 (USD MILLION)
  • TABLE 205. ASEAN NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 206. ASEAN NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 207. ASEAN NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY SPECIALTY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 208. ASEAN NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 209. ASEAN NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY CRANIAL, 2018-2032 (USD MILLION)
  • TABLE 210. ASEAN NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY SPINAL, 2018-2032 (USD MILLION)
  • TABLE 211. ASEAN NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY TRAUMA, 2018-2032 (USD MILLION)
  • TABLE 212. ASEAN NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY TUMOR, 2018-2032 (USD MILLION)
  • TABLE 213. GCC NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 214. GCC NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 215. GCC NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 216. GCC NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY COMPOSITE POLYMERS, 2018-2032 (USD MILLION)
  • TABLE 217. GCC NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 218. GCC NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 219. GCC NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY SPECIALTY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 220. GCC NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 221. GCC NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY CRANIAL, 2018-2032 (USD MILLION)
  • TABLE 222. GCC NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY SPINAL, 2018-2032 (USD MILLION)
  • TABLE 223. GCC NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY TRAUMA, 2018-2032 (USD MILLION)
  • TABLE 224. GCC NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY TUMOR, 2018-2032 (USD MILLION)
  • TABLE 225. EUROPEAN UNION NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 226. EUROPEAN UNION NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 227. EUROPEAN UNION NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 228. EUROPEAN UNION NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY COMPOSITE POLYMERS, 2018-2032 (USD MILLION)
  • TABLE 229. EUROPEAN UNION NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 230. EUROPEAN UNION NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 231. EUROPEAN UNION NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY SPECIALTY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 232. EUROPEAN UNION NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 233. EUROPEAN UNION NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY CRANIAL, 2018-2032 (USD MILLION)
  • TABLE 234. EUROPEAN UNION NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY SPINAL, 2018-2032 (USD MILLION)
  • TABLE 235. EUROPEAN UNION NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY TRAUMA, 2018-2032 (USD MILLION)
  • TABLE 236. EUROPEAN UNION NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY TUMOR, 2018-2032 (USD MILLION)
  • TABLE 237. BRICS NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 238. BRICS NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 239. BRICS NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 240. BRICS NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY COMPOSITE POLYMERS, 2018-2032 (USD MILLION)
  • TABLE 241. BRICS NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 242. BRICS NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 243. BRICS NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY SPECIALTY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 244. BRICS NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 245. BRICS NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY CRANIAL, 2018-2032 (USD MILLION)
  • TABLE 246. BRICS NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY SPINAL, 2018-2032 (USD MILLION)
  • TABLE 247. BRICS NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY TRAUMA, 2018-2032 (USD MILLION)
  • TABLE 248. BRICS NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY TUMOR, 2018-2032 (USD MILLION)
  • TABLE 249. G7 NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 250. G7 NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 251. G7 NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 252. G7 NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY COMPOSITE POLYMERS, 2018-2032 (USD MILLION)
  • TABLE 253. G7 NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 254. G7 NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 255. G7 NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY SPECIALTY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 256. G7 NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 257. G7 NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY CRANIAL, 2018-2032 (USD MILLION)
  • TABLE 258. G7 NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY SPINAL, 2018-2032 (USD MILLION)
  • TABLE 259. G7 NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY TRAUMA, 2018-2032 (USD MILLION)
  • TABLE 260. G7 NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY TUMOR, 2018-2032 (USD MILLION)
  • TABLE 261. NATO NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 262. NATO NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 263. NATO NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 264. NATO NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY COMPOSITE POLYMERS, 2018-2032 (USD MILLION)
  • TABLE 265. NATO NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 266. NATO NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 267. NATO NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY SPECIALTY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 268. NATO NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 269. NATO NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY CRANIAL, 2018-2032 (USD MILLION)
  • TABLE 270. NATO NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY SPINAL, 2018-2032 (USD MILLION)
  • TABLE 271. NATO NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY TRAUMA, 2018-2032 (USD MILLION)
  • TABLE 272. NATO NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY TUMOR, 2018-2032 (USD MILLION)
  • TABLE 273. GLOBAL NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 274. UNITED STATES NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 275. UNITED STATES NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 276. UNITED STATES NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 277. UNITED STATES NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY COMPOSITE POLYMERS, 2018-2032 (USD MILLION)
  • TABLE 278. UNITED STATES NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 279. UNITED STATES NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 280. UNITED STATES NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY SPECIALTY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 281. UNITED STATES NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 282. UNITED STATES NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY CRANIAL, 2018-2032 (USD MILLION)
  • TABLE 283. UNITED STATES NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY SPINAL, 2018-2032 (USD MILLION)
  • TABLE 284. UNITED STATES NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY TRAUMA, 2018-2032 (USD MILLION)
  • TABLE 285. UNITED STATES NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY TUMOR, 2018-2032 (USD MILLION)
  • TABLE 286. CHINA NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 287. CHINA NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 288. CHINA NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 289. CHINA NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY COMPOSITE POLYMERS, 2018-2032 (USD MILLION)
  • TABLE 290. CHINA NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 291. CHINA NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 292. CHINA NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY SPECIALTY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 293. CHINA NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 294. CHINA NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY CRANIAL, 2018-2032 (USD MILLION)
  • TABLE 295. CHINA NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY SPINAL, 2018-2032 (USD MILLION)
  • TABLE 296. CHINA NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY TRAUMA, 2018-2032 (USD MILLION)
  • TABLE 297. CHINA NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY TUMOR, 2018-2032 (USD MILLION)